NASDAQ · VERA

Vera Therapeutics, Inc.

Healthcare · Biotechnology

$33.67

Down-$0.38 (-1.12%)

Updated Sep 16, 2026, 11:42 AM

SID Score

4.8/10

Composite research score

Smart Money

58/100

Neutral

Market cap: 2.94B
P/E ratio: -13.44
Dividend yield: 0.00%
52-week range: $28.86 – $47.00
Volume: 10.49M
Avg. volume: 1.59M

Price performance

VERA price history

1M range · 0 trading sessions · Daily adjusted prices

Data unavailable

Market data is busy. Please try again shortly.

Latest VERA news

The latest Smart Investors Daily articles mentioning VERA.

analystAug 18, 2026

Wedbush Reiterates Neutral Rating on Vera Therapeutics, Inc. (VERA)

analystAug 13, 2026

HC Wainwright & Co. Reiterates Buy Rating on Vera Therapeutics, Inc. (VERA)

analystAug 12, 2026

Wedbush Reiterates Neutral Rating on Vera Therapeutics, Inc. (VERA)

Latest VERA news

The latest Smart Investors Daily articles mentioning VERA.

Stock researchCompany · Dividend

Company

Overview Forecast Earnings Dividend Financials

Market Activity

Options Insider Trades Short Interest Institutional Ownership Sentiment

Research & News

Analysis Competitors News SEC Filings SID Coverage

VERA research

Dividend

Yield, payout details, and dividend history.

Annual dividend: $0.00
Dividend yield: 0.00%
Payout ratio: 0.00%
Latest payment: $0.02

Dividend history

Declared distributions, ex-dividend dates, and payment dates.

VERA dividend history
Ex-date	Payment	Record date	Amount	Type
Jan 10, 1996	—	—	$0.02	Cash
Jun 30, 1995	—	—	$0.02	Cash
Jan 17, 1995	—	—	$0.02	Cash
Jun 13, 1994	—	—	$0.02	Cash
Jan 4, 1994	—	—	$0.02	Cash
Jun 10, 1993	—	—	$0.02	Cash
Dec 8, 1992	—	—	$0.02	Cash
Jun 4, 1992	—	—	$0.02	Cash
Dec 4, 1991	—	—	$0.02	Cash
May 30, 1991	—	—	$0.02	Cash
Dec 11, 1990	—	—	$0.02	Cash
May 25, 1990	—	—	$0.02	Cash

Open dividend calculator

Wedbush Reiterates Neutral Rating on Vera Therapeutics, Inc. (VERA)

HC Wainwright & Co. Reiterates Buy Rating on Vera Therapeutics, Inc. (VERA)

Wedbush Reiterates Neutral Rating on Vera Therapeutics, Inc. (VERA)

Featured By

Wedbush Reiterates Neutral Rating on Vera Therapeutics, Inc. (VERA)

HC Wainwright & Co. Reiterates Buy Rating on Vera Therapeutics, Inc. (VERA)

Wedbush Reiterates Neutral Rating on Vera Therapeutics, Inc. (VERA)